Patient enrollment
MAY, MALIGNANCIES
This retrospective study was approved by the institutional review board of Zhongshan Hospital affiliated to Xiamen University, and informed consent was waived. The Ethical Approval number was XMZSYY-AF-SC-12-03. 259 Patients with histologically confirmed EC by biopsy or surgery, who underwent enhanced CT with SDCT from May 2019 to December 2020 were selected for this study. Exclusion criteria were: (a) chemotherapy or radiotherapy or other anticancer treatments before the IQon CT scans; (b) a history of other malignancies; and (c) incomplete medical records. After excluding 99 cases, 160 patients were finally enrolled in this study and randomized divided into the training dataset (104 patients), validation dataset (26 patients) and test dataset (30 patients). 